Author:
Kronenfeld Joshua P.,Ryon Emily L.,Goldberg David,Lee Rachel M.,Yopp Adam,Wang Annie,Lee Ann Y.,Luu Sommer,Hsu Cary,Silberfein Eric,Russell Maria C.,Livingstone Alan S.,Merchant Nipun B.,Goel Neha
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. HealthIT. Telemedicine and Telehealth. United States Department of Health and Human Services. https://www.healthit.gov/topic/health-it-initiatives/telemedicine-and-telehealth. Published 2017. Accessed 15 Apr 2020.
2. Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1.
3. Sayiner M, Golabi P, Younossi ZM. Disease burden of hepatocellular carcinoma: a global perspective. Dig Dis Sci. 2019;64(4):910–7.
4. Fateen W, Ryder SD. Screening for hepatocellular carcinoma: patient selection and perspectives. J Hepatocell Carcinoma. 2017;4:71–9.
5. Kim SY, An J, Lim YS, et al. MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol. 2017;3(4):456–63.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献